CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Historical Holders from Q4 2015 to Q3 2025

Symbol
CTMX on Nasdaq
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
165,547,872
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
137,376,737
Holdings value
$438,231,708
% of all portfolios
0.002%
Number of holders
101
Number of buys
59
Number of sells
-37
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 12.4% +34.4% $65,458,695 +$16,344,817 20,519,967 +33.3% FMR LLC 31 Oct 2025
Venrock Healthcare Capital Partners III, L.P. 9.4% +15% $49,641,185 +$8,195,110 15,561,500 +19.8% Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
Longitude Capital Partners V, LLC 7.3% $8,192,307 11,538,461 Longitude Capital Partners V, LLC 13 May 2025
TANG CAPITAL MANAGEMENT LLC 7% -17.5% $27,442,842 +$10,782,636 11,065,662 +64.7% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
PERCEPTIVE ADVISORS LLC 5.9% $22,458,029 9,680,185 Perceptive Advisors LLC 14 Aug 2025
VANGUARD GROUP INC 5.95% $21,292,132 9,379,794 The Vanguard Group 30 Jun 2025
ORBIMED ADVISORS LLC 5.4% $20,984,520 8,461,500 OrbiMed Advisors LLC 30 Jun 2025
BIOTECHNOLOGY VALUE FUND L P 3.5% -47.1% $17,250,001 -$17,250,001 5,769,231 -50% BVF PARTNERS L P/IL 03 Jul 2025
Point72 Asset Management, L.P. 2.5% -52% $12,978,754 -$12,811,193 4,068,575 -49.7% Point72 Asset Management, L.P. 30 Sep 2025
Seven Fleet Partners LP 0.2% $267,784 377,161 Seven Fleet Partners LP 13 May 2025
Seven Fleet Capital Management LP 0.02% $155,985 48,898 Seven Fleet Master Fund LP 30 Sep 2025

Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 137,376,737 $438,231,708 +$24,416,720 $3.19 101
2025 Q2 133,305,109 $302,602,132 +$213,797,054 $2.27 82
2025 Q1 45,180,958 $28,723,084 -$1,507,772 $0.6358 63
2024 Q4 46,714,805 $48,111,898 -$6,381,441 $1.03 68
2024 Q3 51,193,741 $60,427,306 +$480,690 $1.18 69
2024 Q2 50,687,257 $61,863,474 +$334,609 $1.22 73
2024 Q1 44,548,308 $97,118,414 +$26,024,246 $2.18 85
2023 Q4 32,640,376 $50,592,909 +$410,206 $1.55 66
2023 Q3 32,393,313 $41,785,804 -$2,418,556 $1.29 61
2023 Q2 34,120,916 $58,688,106 -$2,378,087 $1.72 66
2023 Q1 35,594,054 $53,751,153 -$933,381 $1.51 74
2022 Q4 35,979,014 $120,192,376 -$724,794 $1.6 77
2022 Q3 36,281,610 $52,604,898 -$18,986,577 $1.45 76
2022 Q2 45,579,430 $83,410,352 -$17,825,825 $1.83 86
2022 Q1 53,661,262 $143,355,949 -$1,754,233 $2.67 112
2021 Q4 54,342,875 $235,299,521 -$5,313,006 $4.33 106
2021 Q3 53,978,233 $274,775,521 -$17,338,127 $5.09 111
2021 Q2 56,688,576 $358,879,555 +$4,313,452 $6.33 119
2021 Q1 54,613,642 $422,156,729 +$130,257,296 $7.73 123
2020 Q4 37,995,365 $248,881,255 +$5,576,359 $6.55 123
2020 Q3 36,841,081 $245,069,950 -$11,639,890 $6.65 128
2020 Q2 37,758,348 $314,514,192 +$15,532,613 $8.33 133
2020 Q1 36,087,916 $276,879,388 +$244,869 $7.67 113
2019 Q4 36,001,618 $299,160,261 -$9,333,104 $8.31 119
2019 Q3 35,837,109 $264,433,175 -$1,377,891 $7.38 111
2019 Q2 35,647,194 $399,598,509 -$8,094,164 $11.22 108
2019 Q1 36,897,584 $396,629,592 -$12,805,896 $10.75 110
2018 Q4 37,768,617 $569,884,178 -$2,745,916 $15.1 108
2018 Q3 37,780,542 $697,391,587 +$95,602,749 $18.5 119
2018 Q2 32,308,752 $738,633,935 +$66,042,910 $22.86 139
2018 Q1 28,622,740 $814,197,912 +$73,379,749 $28.45 136
2017 Q4 30,146,848 $636,945,631 +$56,049,834 $21.11 119
2017 Q3 24,242,512 $440,733,363 +$42,038,227 $18.17 97
2017 Q2 22,105,676 $342,719,825 +$44,092,931 $15.5 89
2017 Q1 19,204,130 $331,600,145 +$58,337,064 $17.27 86
2016 Q4 16,857,707 $185,279,386 +$14,954,410 $10.99 68
2016 Q3 19,725,140 $242,759,481 +$18,076,577 $15.68 61
2016 Q2 18,845,409 $149,178,103 +$16,034,432 $10.21 59
2016 Q1 12,778,869 $164,816,000 +$3,379,204 $12.9 47
2015 Q4 12,469,279 $258,260,359 +$239,918,359 $20.87 47